CCCC
Price
$3.94
Change
+$0.08 (+2.07%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
278.12M
33 days until earnings call
RLAY
Price
$4.46
Change
+$0.13 (+3.01%)
Updated
Jan 17, 04:59 PM (EDT)
Capitalization
746.53M
33 days until earnings call
Ad is loading...

CCCC vs RLAY

Header iconCCCC vs RLAY Comparison
Open Charts CCCC vs RLAYBanner chart's image
C4 Therapeutics
Price$3.94
Change+$0.08 (+2.07%)
Volume$6K
Capitalization278.12M
Relay Therapeutics
Price$4.46
Change+$0.13 (+3.01%)
Volume$89.38K
Capitalization746.53M
CCCC vs RLAY Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. RLAY commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and RLAY is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (CCCC: $3.86 vs. RLAY: $4.32)
Brand notoriety: CCCC and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 89% vs. RLAY: 192%
Market capitalization -- CCCC: $278.12M vs. RLAY: $746.53M
CCCC [@Biotechnology] is valued at $278.12M. RLAY’s [@Biotechnology] market capitalization is $746.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 2 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 3 bearish.
  • RLAY’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, CCCC is a better buy in the short-term than RLAY.

Price Growth

CCCC (@Biotechnology) experienced а +0.52% price change this week, while RLAY (@Biotechnology) price change was -10.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.05%. For the same industry, the average monthly price growth was +3.04%, and the average quarterly price growth was -1.59%.

Reported Earning Dates

CCCC is expected to report earnings on May 08, 2025.

RLAY is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($747M) has a higher market cap than CCCC($278M). CCCC YTD gains are higher at: 7.222 vs. RLAY (4.854). CCCC has higher annual earnings (EBITDA): -103.45M vs. RLAY (-389.45M). RLAY has more cash in the bank: 840M vs. CCCC (256M). RLAY has less debt than CCCC: RLAY (49.8M) vs CCCC (67.1M). CCCC has higher revenues than RLAY: CCCC (33.7M) vs RLAY (10M).
CCCCRLAYCCCC / RLAY
Capitalization278M747M37%
EBITDA-103.45M-389.45M27%
Gain YTD7.2224.854149%
P/E RatioN/AN/A-
Revenue33.7M10M337%
Total Cash256M840M30%
Total Debt67.1M49.8M135%
TECHNICAL ANALYSIS
Technical Analysis
CCCCRLAY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
79%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
Bullish Trend 5 days ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 5 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
85%
View a ticker or compare two or three
Ad is loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY591.64-1.14
-0.19%
SPDR® S&P 500® ETF Trust
BTC.X99756.910000-747.585940
-0.74%
Bitcoin cryptocurrency
GME27.72-0.24
-0.86%
GameStop Corp
TSLA413.82-14.40
-3.36%
Tesla
AAPL228.26-9.61
-4.04%
Apple

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-4.46%
KYMR - CCCC
61%
Loosely correlated
-7.51%
CRSP - CCCC
50%
Loosely correlated
+3.23%
FATE - CCCC
49%
Loosely correlated
-5.30%
BEAM - CCCC
49%
Loosely correlated
+0.04%
PRME - CCCC
48%
Loosely correlated
+0.35%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+13.39%
XNCR - RLAY
50%
Loosely correlated
-0.10%
CCCC - RLAY
45%
Loosely correlated
-4.46%
RXRX - RLAY
43%
Loosely correlated
-0.31%
ABOS - RLAY
41%
Loosely correlated
-5.85%
TVTX - RLAY
41%
Loosely correlated
+2.21%
More